欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2021, Vol. 26 ›› Issue (12): 1360-1369.doi: 10.12092/j.issn.1009-2501.2021.12.004

• 基础研究 • 上一篇    下一篇

化痰降气胶囊含药血清调控Nrf2/HDAC2改善16HBE细胞糖皮质激素抵抗

王梦文1,郭 艳2,王重阳1,陶福林1,朱文涛1,韩智莉1,孙念霞1,李泽庚3,汪电雷1,4   

  1. 1安徽中医药大学药学院,合肥 230012,安徽;2阜阳市第六人民医院药学部,阜阳 236000,安徽;
    3安徽中医药大学第一附属医院,合肥 230031,安徽;4安徽省中药研究与开发重点实验室,合肥 230012,安徽
  • 收稿日期:2021-08-24 修回日期:2021-10-30 出版日期:2021-12-26 发布日期:2022-01-07
  • 通讯作者: 汪电雷,通信作者,男,教授,博士生导师,主要从事中药药物代谢动力学及转运体研究。 Tel: 0551-68129153 E-mail: wdl8105@126.com 李泽庚,共同通信作者,男,教授,博士生导师,主要从事中医药防治呼吸系统疾病的临床研究。 Tel: 0551-62850171 E-mail: li6609@126.com
  • 作者简介:王梦文,女,硕士研究生,主要从事药物转运体研究。 E-mail: wmw24008@126.com
  • 基金资助:
    国家自然科学基金资助项目(81473536);安徽省杰出青年科学基金(2108085J45)

Huatanjiangqi capsule regulates Nrf2/HDAC2 and improves glucocorticoid resistance of 16HBE cells

WANG Mengwen1, GUO Yan2, WANG Chongyang1, TAO Fulin1, ZHU Wentao1, HAN Zhili1, SUN Nianxia1, LI Zegeng3, WANG Dianlei1,4   

  1. 1School of Pharmacy, Anhui University of Chinese Medicine, Anhui 230012, Hefei, China; 2Department of Pharmacy, Fuyang Sixth People's Hospital, Anhui 236000, Fuyang, China; 3The First Afliated Hospital to Anhui University of Chinese Medicine, Anhui 230031, Hefei, China; 4Anhui Province Key Laboratory of Research & Development of Chinese Medicine, Anhui 230012, Hefei, China

  • Received:2021-08-24 Revised:2021-10-30 Online:2021-12-26 Published:2022-01-07

摘要: 目的:探讨化痰降气胶囊含药血清(HTJQ)对香烟烟雾提取物(cigarette smoke extract, CSE)刺激下的人支气管上皮细胞(16HBE)糖皮质激素(glucocorticoid, GC)抵抗的影响。方法:16HBE细胞经HTJQ处理后,CCK-8法测定不同浓度HTJQ对16HBE细胞活力的影响。HTJQ预先处理16HBE细胞,然后依次用地塞米松(DEX)和脂多糖(LPS)培养24 h,酶联免疫吸附试验(ELISA)测定HTJQ对16HBE细胞糖皮质激素抵抗的影响。Western blot法分别测定HTJQ、萝卜硫素(SFN)和谷胱甘肽(GSH)对CSE刺激下16HBE细胞NF-E2相关因子2(Nrf2)、血红素加氧酶-1(HO-1)、组蛋白去乙酰化酶2(HDAC2)的表达;ELISA分别测定HTJQ、SFN和GSH对16HBE细胞白细胞介素-8(IL-8)的影响。结果:HTJQ在1 h、2 h、4 h下均促进16HBE细胞增殖;ELISA和Western blot结果显示,CSE导致16HBE细胞GC抵抗(P<0.01),Nrf2、HO-1、HDAC2的表达降低(P<0.01);HTJQ显著降低IL-8,改善16HBE细胞GC敏感性(P<0.01),并上调Nrf2、HO-1、HDAC2的表达(P<0.01)。此外HTJQ显著上调16HBE细胞内GSH水平(P<0.01)。Nrf2激动剂SFN和GSH均显著改善16HBE细胞的糖皮质激素敏感性(P<0.01),上调Nrf2、HO-1、HDAC2的表达(P<0.01)。 结论:HTJQ胶囊通过上调Nrf2/HDAC2蛋白表达和细胞内GSH水平,从而改善16HBE细胞GC抵抗。

关键词: 化痰降气胶囊, 慢性阻塞性肺病, 糖皮质激素抵抗, Nrf2, 组蛋白去乙酰化酶2, 谷胱甘肽

Abstract: AIM: To explore the effect of Huatanjiangqi capsule medicated serum (HTJQ) on the resistance of human bronchial epithelial cells (16HBE) to glucocorticoid (GC) stimulated by cigarette smoke extract (CSE).  METHODS: After 16HBE cells were treated with HTJQ, the effects of different concentrations of HTJQ on the viability of 16HBE cells were determined by CCK-8 method. 16HBE cells were pretreated with HTJQ, and then cultured with dexamethasone (DEX) and lipopolysaccharide (LPS) for 24 hours, the effect of HTJQ on glucocorticoid (GC) resistance of 16HBE cells was determined by Enzyme-linked immunosorbent assay (ELISA). The effects of HTJQ, sulforaphane (SFN) and glutathione (GSH) on the expression of NF-E2-related factors 2 (Nrf2), Heme oxygenase-1 (HO-1) and histone deacetylase 2 (HDAC2) in 16HBE cells stimulated by CSE were measured by Western blot, and the effects of HTJQ, SFN and GSH on interleukin-8 (IL-8) in 16HBE cells were measured by ELISA. RESULTS: HTJQ promoted the proliferation of 16HBE cells at 1 h, 2 h and 4 h, the results of ELISA and Western blot showed that CSE induced GC resistance and decreased the expression of Nrf2, HO-1 and HDAC2 in 16HBE cells, HTJQ significantly decreased IL-8 and improved GC sensitivity of 16HBE cells (P<0.01), and up-regulated the expression of Nrf2, HO-1 and HDAC2 (P<0.01). In addition, HTJQ significantly up-regulated the level of GSH in 16HBE cells (P<0.01). Nrf2 agonists SFN and GSH significantly improved the glucocorticoid sensitivity of 16HBE cells (P<0.01), and up-regulated the expression of Nrf2, HO-1 and HDAC2 (P<0.01). CONCLUSION: HTJQ improves the GC resistance of 16HBE cells by up-regulating the expression of Nrf2/HDAC2 protein and the level of intracellular GSH.

中图分类号: